期刊
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
卷 39, 期 8, 页码 483-494出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2018.0166
关键词
interleukin 27; prostate cancer; toll-like receptor 3; interferon; poly I; C; apoptosis; proliferation
资金
- Prostate Cancer Fight Foundation
- TELUS Ride for Dad
- Ontario Graduate Scholarship
- Dr. Robert John Wilson Graduate Fellowship
- NSERC-PGS D
Interleukin (IL)-27 is a promising anti-cancer cytokine with therapeutic potential. Exhibiting overlapping properties with type I and II interferons (IFNs), IL-27 impacts cancer cell viability and immune cell activity. Known to modulate toll-like receptor (TLR) expression, we investigated whether IL-27 affected TLR-mediated death in cancer cells. Using DU145 and PC3 cell lines as models of prostate cancer, we investigated whether IL-27 and IFN-gamma affect TLR3-mediated cell death. Our results demonstrate that when IL-27 or IFN-gamma is added with polyinosinic-polycytidylic acid [poly(I:C)], type I IFN (IFN-I) expression increases concurrently with cell death. IL-27 and IFN-gamma enhanced TLR3 expression, suggesting a mechanism for sensitization to cell death. Further, PC3 cells were more sensitive to IL-27/poly(I:C)-induced cell death compared with DU145 cells. This correlated with higher production of IFN-beta and inducible protein-10 versus IL-6 in response to treatment of PC3 cells compared with DU145. Taken together, this study demonstrates a potential role for IL-27 in the treatment of prostate cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据